XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Inventories (Tables)
9 Months Ended
Sep. 30, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current
At September 30, 2024 and December 31, 2023, the Company's net inventories consisted of the following:
September 30, 2024December 31, 2023
Raw materials and work in process$12,306,377 $12,619,092 
Consigned inventory154,992 149,701 
Finished goods3,880,227 4,645,098 
Total inventories16,341,596 17,413,891 
less non-current inventories(11,831,927)(12,804,529)
Total inventories classified as current$4,509,669 $4,609,362 
Schedule of Inventory, Noncurrent
At September 30, 2024 and December 31, 2023, the Company's non-current inventories consisted of the following:
September 30, 2024December 31, 2023
Vibativ Raw Materials$6,230,671 $6,611,426 
Kristalose Raw Materials2,850,484 3,263,516 
Vaprisol Raw Materials1,173,442 1,170,641 
Sancuso Raw Materials626,876 574,502 
Caldolor Raw Materials31,488 — 
Acetadote Raw Materials26,585 33,678 
Ifetroban Raw Materials203,383 203,383 
Vibativ Finished Goods486,942 810,454 
Sancuso Finished Goods46,602 — 
Caldolor Finished Goods54,315 67,307 
Acetadote Finished Goods31,517 — 
Omeclamox69,622 69,622 
Total inventories classified as non-current$11,831,927 $12,804,529